NBI-98854
Modify Date: 2024-01-07 12:41:53
NBI-98854 structure
|
Common Name | NBI-98854 | ||
|---|---|---|---|---|
| CAS Number | 171598-74-6 | Molecular Weight | 319.44 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C19H29NO3 | Melting Point | 167-170°C | |
| MSDS | N/A | Flash Point | N/A | |
Use of NBI-98854NBI-98854 is a potent, highly selective, VMAT2 inhibitor that is effective in regulating the levels of dopamine release during nerve communication.IC50 value:Target: VMAT2NBI-98854 completed a Phase I single ascending dose clinical trial in healthy male volunteers in Canada under an approved Clinical Trial Application with Health Canada.This trial showed NBI-98854 to be generally safe and well tolerated. |
| Name | NBI-98854 |
|---|
| Description | NBI-98854 is a potent, highly selective, VMAT2 inhibitor that is effective in regulating the levels of dopamine release during nerve communication.IC50 value:Target: VMAT2NBI-98854 completed a Phase I single ascending dose clinical trial in healthy male volunteers in Canada under an approved Clinical Trial Application with Health Canada.This trial showed NBI-98854 to be generally safe and well tolerated. |
|---|---|
| Related Catalog | |
| References |
[1]. NBI-98854 - Vesicular Monoamine Transporter 2 Inhibitor (VMAT2). |
| Melting Point | 167-170°C |
|---|---|
| Molecular Formula | C19H29NO3 |
| Molecular Weight | 319.44 |
| Storage condition | Refrigerator |